Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, 3-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Doses of J867 (0.5, 1.5 and 5 mg QD) Versus Placebo in Subjects With Endometriosis

NCT00160433 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00160433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00160433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, 3-Month, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Doses of J867 (0.5, 1.5 and 5 mg QD) Versus Placebo in Subjects With Endometriosis
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2002
Completion date
June 30, 2003
Enrollment
131 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis